Rolston, Kenneth V.I.
October 2003
Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1143
Academic Journal
Comments on several issues related to infectious diseases in the U.S. Reliability of the diagnostic test for pneumococcal infection; Guidelines for therapeutic decisions in cases of community-acquired pneumonia; Epidemiology of nosocomial bloodstream infections in patients with hematologic malignancies and solid tumors.


Related Articles

  • Economic evaluation of pneumococcal conjugate vaccination in The Gambia. Sun-Young Kim; Gene Lee; Goldie, Sue J. // BMC Infectious Diseases;2010, Vol. 10 Issue 1, p260 

    Background: Gambia is the second GAVI support-eligible country to introduce the 7-valent pneumococcal conjugate vaccine (PCV7), but a country-specific cost-effectiveness analysis of the vaccine is not available. Our objective was to assess the potential impact of PCVs of different valences in...

  • Effect of Antiviral Treatment on the Outcome of Secondary Bacterial Pneumonia after Influenza. McCullers, Jonathan A. // Journal of Infectious Diseases;8/1/2004, Vol. 190 Issue 3, p519 

    Secondary bacterial pneumonia is an important cause of influenza-associated death. Although antibacterial therapy is standard, antiviral therapy has been ignored because viral infections usually resolve by the time bacterial pneumonia presents. In the present study, antiviral compounds were...

  • An individual-based network model to evaluate interventions for controlling pneumococcal transmission. Karlsson, Diana; Jansson, Andreas; Normark, Birgitta Henriques; Nilsson, Patric // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide, but Salso a common colonizer of the upper respiratory tract. The emergence and spread of antibiotic resistant pneumococcal strains has threatened effective therapy. The long-term effects of measures...

  • Initial and Subsequent Response to Pneumococcal Polysaccharide and Protein-Conjugate Vaccines Administered Sequentially to Adults Who Have Recovered from Pneumococcal Pneumonia. Musher, Daniel M.; Rueda, Adriana M.; Nahm, Moon H.; Graviss, Edward A.; Rodriguez-Barradas, Maria C. // Journal of Infectious Diseases;10/1/2008, Vol. 198 Issue 7, p1019 

    Background. Controversy persists over the benefits of pneumococcal polysaccharide vaccine (PPV) for adults at high risk for pneumococcal disease. We studied PPV, protein-conjugate pneumococcal vaccine (PCV), and immunologic "priming" with PCV followed by "boosting" with PPV in adults who had...

  • Pneumococcal Surface Protein A Contributes to Secondary Streptococcus pneumoniae Infection after Influenza Virus Infection. King, Quinton O.; Benfang Lei; Harmsen, Allen G. // Journal of Infectious Diseases;8/15/2009, Vol. 200 Issue 4, p537 

    We compared the growth of Streptococcus pneumoniae mutants with a disruption in the gene for either pneumococcal surface protein A (PspA-), neuraminidase A (NanA-), or hyaluronidase (Hyl-) to that of the parental strain D39 by means of a competitive growth model in mice with and those without...

  • Age-Associated Inflammation and Toll-Like Receptor Dysfunction Prime the Lungs for Pneumococcal Pneumonia. Hinojosa, Ernesto; Boyd, Angela R.; Orihuela, Carlos J. // Journal of Infectious Diseases;8/15/2009, Vol. 200 Issue 4, p546 

    Background. Aging is associated with increased inflammation and risk of community-acquired pneumonia. Streptococcus pneumoniae co-opts the nuclear factor κ B (NFkB)-regulated proteins polymeric immunoglobulin receptor (pIgR) and platelet-activating factor receptor (PAFr) to attach and invade...

  • Errata.  // Journal of Infectious Diseases;3/1/2008, Vol. 197 Issue 5, p779 

    A correction to the article "Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media," by B. Simell, M. Melin, and M. Lahdenkari that was published in the November 15, 2007 issue is presented.

  • Understanding S. Pneumoniae. Corry, Margarita; Whelan, Jacqueline // World of Irish Nursing & Midwifery;Sep2006, Vol. 14 Issue 8, p55 

    The article discusses the nature of streptococcus pneumonia also known as the pneumococcal pneumonia, a potentially vaccine-preventable disease which is among the leading causes of illness and death in young children worldwide. The disease is caused by an anaerobic gram positive bacterium. It is...

  • Pneumococcal Carriage among Indigenous Warao Children in Venezuela: Serotypes, Susceptibility Patterns, and Molecular Epidemiology. Rivera-Olivero, Ismar A.; Bogaert, Debby; Bello, Teresita; del Nogal, Berenice; Sluijter, Marcel; Hermans, Peter W. M.; de Waard, Jacobus H. // Clinical Infectious Diseases;12/1/2007, Vol. 45 Issue 11, p1427 

    Little attention has been paid to pneumococcal carriage and disease in Amerindians from Latin America. The Warao people, an indigenous population from Venezuela, live in the delta of the Orinoco River in geographically isolated communities with difficult access to medical care. To obtain insight...

  • Comparison of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus Pulsotypes USA300 and USA400 in a Rat Model of Pneumonia. Montgomery, Christopher P.; Boyle-Vavra, Susan; Adem, Patricia V.; Lee, Jean C.; Husain, Aliya N.; Clasen, Julia; Daum, Robert S. // Journal of Infectious Diseases;8/15/2008, Vol. 198 Issue 4, p561 

    Background. The predominant genetic background of community-associated methicillin-resistant Staphylococcus aureus has transitioned from USA400 to USA300 in most US communities. The explanation for this shift is unclear. We hypothesized that USA300 must be more pathogenic—specifically,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics